Literature DB >> 23636292

A patient with severely reduced LV function and electrical storm saved by wearable cardioverter-defibrillator: a case report.

Margit Strauss1, Kleopatra Kouraki, Alexandros Skarlos, Ralf Zahn, Thomas Kleemann.   

Abstract

The wearable cardioverter-defibrillator (WCD) is indicated in patients who are considered to be at temporarily high risk for sudden cardiac death (SCD), when an implantable defibrillator is not yet clearly indicated. We report the case of a 41-year-old patient with a newly diagnosed severely reduced left ventricular (LV) function for suspected myocarditis and repeated nonsustained ventricular tachycardia (VT). This patient was supplied with a WCD who came back to the hospital 4 weeks after discharge with an electrical storm and adequate discharge of the WCD. After application of amiodarone, no further arrhythmias were detected during intrahospital course. For further risk stratification, we performed a magnetic field imaging (MFI), that was reported to be useful in risk assessment of SCD in patients with ischemic cardiomyopathy. This measurement showed a normal result, but we decided to give an implantable cardioverter-defibrillator (ICD) to the patient. During a follow-up of 1 year, no further arrhythmias occurred. With this case, we report the efficacy of a WCD, which is a novel tool in patients at temporarily high risk of SCD and we report a novel method of risk stratification in patients with a high risk of SCD.

Entities:  

Mesh:

Year:  2013        PMID: 23636292     DOI: 10.1007/s00399-013-0264-8

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  6 in total

1.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Europace       Date:  2006-08-25       Impact factor: 5.214

2.  [Guidelines for the implantation of defibrillators].

Authors:  W Jung; D Andresen; M Block; D Böcker; S H Hohnloser; K-H Kuck; J Sperzel
Journal:  Clin Res Cardiol       Date:  2006-12       Impact factor: 5.460

Review 3.  Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).

Authors:  Helmut U Klein; Ulf Meltendorf; Sven Reek; Jan Smid; Sebastian Kuss; Iwona Cygankiewicz; Christian Jons; Steven Szymkiewicz; Frank Buhtz; Anke Wollbrueck; Wojciech Zareba; Arthur J Moss
Journal:  Pacing Clin Electrophysiol       Date:  2009-11-02       Impact factor: 1.976

4.  Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death.

Authors:  J Kron; M Hart; S Schual-Berke; N R Niles; J D Hosenpud; J H McAnulty
Journal:  Chest       Date:  1988-01       Impact factor: 9.410

5.  Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction.

Authors:  Petri Korhonen; Terhi Husa; Ilkka Tierala; Heikki Väänänen; Markku Mäkijärvi; Toivo Katila; Lauri Toivonen
Journal:  J Cardiovasc Electrophysiol       Date:  2006-04

6.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.

Authors:  A Gradman; P Deedwania; R Cody; B Massie; M Packer; B Pitt; S Goldstein
Journal:  J Am Coll Cardiol       Date:  1989-09       Impact factor: 24.094

  6 in total
  2 in total

Review 1.  The Wearable Cardioverter/Defibrillator - Toy Or Tool?

Authors:  David Duncker; Christian Veltmann
Journal:  J Atr Fibrillation       Date:  2016-04-30

2.  Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.

Authors:  Maura M Zylla; Henrike A K Hillmann; Tanja Proctor; Meinhard Kieser; Eberhard Scholz; Edgar Zitron; Hugo A Katus; Dierk Thomas
Journal:  Heart Vessels       Date:  2018-05-02       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.